Clinical Trials Logo

Disease clinical trials

View clinical trials related to Disease.

Filter by:

NCT ID: NCT01418339 Completed - Tourette's Disorder Clinical Trials

Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

Start date: July 27, 2011
Phase: Phase 3
Study type: Interventional

The goal of the current study is to determine efficacy and safety of once-weekly aripiprazole in reducing Total Tic Severity (TTS) score in children and adolescents with Tourette's Disorder.

NCT ID: NCT01416805 Completed - Clinical trials for Generalized Anxiety Disorder

Computerized Cognitive Behavioral Therapy for Childhood Anxiety in Community Health Centers

Start date: August 2011
Phase: Phase 3
Study type: Interventional

This study will examine the efficacy of a computerized cognitive behavioral therapy (CCBT) program for children with anxiety disorders in community health centers. The first phase of the study will offer insight into the feasibility of providing this intervention in community health centers, while the second phase will compare CCBT to treatment as usual.

NCT ID: NCT01416441 Completed - Tourette's Disorder Clinical Trials

Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

Start date: October 19, 2011
Phase: Phase 3
Study type: Interventional

The goal of the current trial is to obtain long term efficacy, safety and tolerability data of once weekly aripiprazole in children and adolescents with Tourette's Disorder.

NCT ID: NCT01415154 Completed - Clinical trials for Major Depressive Disorder

Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder

Start date: August 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy of scheduled maintenance Transcranial Magnetic Stimulation (TMS) treatment compared to on-demand TMS treatment for symptomatic worsening in patients who have shown a clinical response to acute TMS treatment.

NCT ID: NCT01410357 Completed - Depression Clinical Trials

Improving Outcomes for Individuals With Serious Mental Illness and Diabetes

TTIM
Start date: July 2011
Phase: N/A
Study type: Interventional

This project tests a model for improving illness self-management among persons who have both serious mental illness and diabetes and will be performed within a primary care setting at a safety net hospital system. The information gained from the randomized trial will be supplemented with reports from participants about their experiences of trying to improve illness self-management. Improvements in self-management should result in a reduction of psychiatric symptoms and improvements in functioning and physical health.

NCT ID: NCT01409096 Completed - Clinical trials for Major Depressive Disorder

Study Using Pregnenolone to Treat Bipolar Depression

Start date: March 2010
Phase: Phase 4
Study type: Interventional

Primary purpose of this study is to determine if pregnenolone supplementation is associated with greater improvement in depressive symptoms of patients with bipolar disorder. Also the study will explore possibilities of improving anxiety and manic symptoms as well as the patient's cognition.

NCT ID: NCT01407575 Completed - Depression Clinical Trials

Buprenorphine for Treatment Resistant Depression

BUP-TRD
Start date: September 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the safety and efficacy of buprenorphine with placebo for adults with treatment resistant depression (TRD).

NCT ID: NCT01401244 Completed - Healthy Clinical Trials

Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers

Start date: July 14, 2011
Phase: Phase 1
Study type: Interventional

This trial is conducted in United States of America (USA). The aim of this trial is to examine the bioequivalence of Norditropin® versus Genotropin® in healthy adult volunteers.

NCT ID: NCT01395160 Completed - Bipolar Disorder Clinical Trials

Female Experiences and Brain Activity

FEBA
Start date: July 2011
Phase: N/A
Study type: Observational

The Female Experiences and Brain Activity study will investigate how different groups of people process information in different ways. Using electro-physiological methods it will investigate differences in brain activity between women with ADHD, women with bipolar disorder and those without a psychiatric illness. It will also investigate the relationship between patterns of brain activity, mood and functioning.

NCT ID: NCT01392989 Completed - Anemia Clinical Trials

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Start date: March 2011
Phase: Phase 2
Study type: Interventional

Allogeneic stem cell transplantation (transplant of blood cells from another individual) is a treatment option for patients with myelodysplasia or myeloproliferative Disorders. During the course of this study, it will be evaluated whether a particular type of blood cell, called a cytokine-induced killer (CIK) cell, may add benefit to allogeneic stem cell transplantation. CIK cells are present in small quantities in the bloodstream but their numbers can be expanded after a brief period of nurturing in a laboratory.